Strategic Partnerships BCAN actively collaborates with major pharmaceutical companies such as Ferring Pharmaceuticals, Pfizer, and the Astellas/Pfizer Alliance, indicating a strong openness to partnership opportunities in research funding, patient programs, and health initiatives.

Fundraising and Revenue With an annual revenue ranging from 10 to 25 million dollars, BCAN demonstrates robust funding capacity, presenting potential for corporate sponsorships, donations, and grants to expand program reach and impact.

Event Engagement Regular participation in high-profile events like Walks to End Bladder Cancer and the Spring Bladder Cancer Summit showcases BCAN's active community engagement and public awareness campaigns, providing opportunities for brand visibility and sponsorship.

Research Innovation BCAN's initiatives such as the Translational Clinical Trial Award and development of funding mechanisms for biospecimen research highlight their focus on advancing bladder cancer science, creating opportunities for partnerships in research technology and data sharing.

Digital Presence Utilizing a comprehensive digital marketing stack including Google Ads, Analytics, and social media tools, BCAN offers channels for digital campaigns, outreach programs, and targeted initiatives to raise awareness and attract supporters or collaborators.